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BETA-BLOCKER STUDY HALTED; A major c l i n i c a l study of coronary heart 
BUMC ONE OF 32 STUDY SITES disease conducted by the National Pfeart, 
Lung and Blood I n s t i t u t e at the Medical 
Center and 30 other c l i n i c a l t r i a l s i t e s across the nation and one i n Canada 
has been halted e a r l i e r than planned because of dramatically positive results. 
Ihe NHLBI took t h i s unusual step because data from the Beta-Blocker ffeart 
Attack T r i a l showed that a group of post-heart attack patients receiving the 
drug propranolol over a 24-month period had a 26-percent lower t o t a l mortality 
rate than patients i n a control group who received a placebo. 
Propranolol, also known as Inderal, i s a drug commonly used i n c l i n i c a l 
practice f o r the treatment of recurrent chest pain (angina p e c t o r i s ) , 
hypertension and cardiac rhythm i r r e g u l a r i t i e s . I h i s drug, therefore, i s 
readily available f o r immediate use by heart attack patients. 
"Ihe 26-percent reduction i n t o t a l m o r t a l i t y rate observed i n the group 
treated with propranolol following an acute heart attack corresponds to a very 
high l e v e l of s t a t i s t i c a l significance, thereby strengthening the conclusion 
that the drug exerts a beneficial e f f e c t on those who have had heart attacks," 
said l i n t e l S. VDkonas, M.D., an associate professor of medicine at BUSM and 
p r i n c i p a l investigator of the study at the Medical Center. 
Ihe national study, which involved 3,837 patients, was begun i n 1978 and 
was scheduled t o end i n the spring of 1982. Formal announcement of the 
decision t o c a l l o f f the study was made by the NHLBI Oct. 29 i n Bethesda, Md. 
The results of the BHAT study strengthen and extend conclusions of 
previous studies of beta-blockers i n survivors of acute myocardial i n f a r c t i o n , 
and indicate that the beneficial effects of propranolol appear to occur 
pr i m a r i l y i n the f i r s t year following myocardial i n f a r c t i o n . 
"Ihese studies c l e a r l y have implications of great c l i n i c a l importance i n 
the future management of individuals with MI as we l l as other forms of 
coronary heart disease. Ihe o v e r a l l magnitude of t h i s p o t e n t i a l benefit, 
however, cannot be determined by t h i s study alone, since many patients already 
receiving propranolol f o r complications of t h e i r heart attacks, such as 
unstable chest pain, were excluded from consideration i n the study," \t)konas 
explained. 
The BUMC c l i n i c a l t r i a l was the f i f t h largest national s i t e . I t involved 
141 heart attack patients, ages 30 t o 69, at six Boston area hospitals: 
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Boston City Hbspital, University Hospital, Maiden Hospital, Carney Hospital, 
Whidden Memorial Hospital and St. Elizabeth's Hospital. Lorraine M. Kilcoyne, 
R.N., was c l i n i c a l coordinator of the BUMC study. 
The national BHAT study began i n June 1978. A t o t a l of 3,837 men and 
women with documented myocardial i n f a r c t i o n were enrolled and randonized i n t o 
one of two study groups: 1,916 were given propranolol and 1,921 were given the 
placebo. Ihe two groups of patients were closely matched with regard t o 
demographic factors, known cardiac r i s k factors, medical history, use of 
medications, physical findings and laboratory data. Patients i n the "high 
r i s k " category, such as those with congestive heart f a i l u r e or those who 
required beta-blocker therapy, were excluded from the study. (Ihe term 
"beta-blocker" refers t o a drug that blocks nerve endings called beta 
receptors that regulate the strength and frequency of muscle contractions i n 
the heart.) 
As of October, the data showed a mor t a l i t y rate of 9.5 percent i n the 
placebo group (183 deaths) and 7.0 percent i n the propranolol group (135 
deaths), a reduction of 26 percent. Patients i n the propranolol group also 
did not have s i g n i f i c a n t l y increased frequency of congestive heart f a i l u r e . 
Such side e f f e c t s as low blood pressure, tiredness, depression, impotence and 
gast r o i n t e s t i n a l problems, however, were more common i n patients who received 
propranolol. 
The Veteran's Administration Medical Center i n West Roxbury, Mass., was 
another t e s t s i t e i n the study. Kevin M. Mclntyre, M.D., and William E. 
Strauss, M.D., co-investigators, directed that t r i a l , which enrolled 110 
patients from s i x New England area VA hospitals. Patricia Woods^^.N., was 
the c l i n i c a l coordinator at the West Roxbury t r i a l s i t e . 
LCME AWARDS SCHDOL OF MEDICINE Ihe Liaison Committee on Medical Education, 
EIGHT-YEAR RE-ACCREDITATION an accrediting body of the American Medical 
Association and the Association of American 
Medical Colleges, has voted t o re-accredit the School of Medicine f o r eight 
years, according t o University President John R. Silber, Ph.D., and Dean 
Sandson. 
Ihe Committee voted t o confer continuing f u l l accreditation on the School 
at i t s Oct. 14 meeting. Ihe next review of the BUSM medical education program 
leading t o the M.D. degree, therefore, w i l l be during the 1988-89 academic 
year. 
Accreditation i s awarded t o the School on the basis of judgment that 
there i s an appropriate balance between the size of enrollment i n each class 
and the t o t a l resources of the i n s t i t u t i o n , including the f a c u l t y , physical 
f a c i l i t i e s and the operating budget. Ihe School was l a s t accredited i n 1973. 
In preparation f o r re-accreditation, the School of Medicine conducted an 
intensive self-evaluation that began i n early 1979. Numerous committees at 
the School examined such varied matters as BUSM's administrative structure, 
curriculum evaluation procedures and student f i n a n c i a l aid. A report on the 
committees' findings was submitted t o the LCME l a s t October. 
Ihe LCME conducted a four-day s i t e v i s i t at the School l a s t Deconber. 
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0'CONNOR AND BROIIMAN RECEIVE John F. O'Connor, M.D., a professor of 
OFFICE OF ADMISSIONS POSTS radiology, and Selwyn A. Broitman, Eh.D., a 
professor of microbiology, were appointed 
associate and assistant deans of admissions at BUSM, respectively, by the 
University's Board of Trustees at i t s Oct. 29 meeting. 
O'Connor, who has been assistant dean of admissions at the School since 
1975, has been acting associate dean since the sudden death l a s t March of 
Jacob Swartz, M.D. 
A 1957 graduate of the School of Medicine, O'Connor joined the BUSM 
faculty i n 1965. In addition to his f a c u l t y position i n the Department of 
Radiology, he i s a professor of pediatrics and anatomy. He also i s director 
of pediatric radiology at Boston City ffospital and i s chief radiologist at 
Kennedy Memorial Hospital i n Brighton, Mass. 
Broitman, who has been a member of the BUSM fa c u l t y since 1969, also i s 
an associate professor of n u t r i t i o n a l sciences at the Goldman School of 
Graduate Dentistry, ffe i s a member of the Special S c i e n t i f i c Staff 
(pathology) at Boston City ffospital, and i s a research associate at the 
Mallory I n s t i t u t e of lathology's Nutrition-Pathology Unit. He has received 
several honors, including the School of Medicine's 1976 Teaching Award. 
RICHARD WURIMAN IS SECOND flLchard J. Wurtman, M.D., a professor of 
BUSM STERLING DRUG PROFESSOR neuroendocrine regulation at the Massachusetts 
I n s t i t u t e of Technology, i s the School of 
Medicine's second Sterling Drug V i s i t i n g Professor. His keynote address, t o 
be presented Thursday, Dec. 3, at 4 p.m. i n Keefer Auditorium, i s e n t i t l e d 
"Ihe C l i n i c a l Pharmacology of Nutrients Affecting Neurotransmission." Ihe 
lecture i s open to a l l members of the Medical Center community. Wurtman, who 
w i l l be at the School from Nov. 30 to Dec. 5, also w i l l meet with members of 
the Cardiovascular I n s t i t u t e and members of the [Departments of Neurology, 
Pharmacology, and Biochemistry. 
The annual v i s i t i n g professorship was established i n July 1979 when the 
School became the f i r s t medical school i n the country to receive a $50,000 
endowment from Sterling Drug, Inc., of New York City. 
ACKER, EDELIN TO TAKE PAId? IN David Acker, M.D., an associate professor of 
OB-GYN CME COURSE IN DECEMBER obstetrics and gynecology, i s course director 
of " C l i n i c a l Obstetrics and Gynecology," a 
continuing medical education course offered Dec. 27 to 31 at the Orlando ffyatt 
ffotel i n Orlando, Fla. 
Acker and Kenneth C. Edelin, M.D., chairman of the IDepartment of 
Obstetrics and Gynecology, w i l l each moderate two sets of discussions i n 
addition t o discussing such topics as pelvic inflammatory disease, adolescent 
pregnancy and f e t a l r i g h t s , and chronic hypertension i n pregnancy. 
Other participants w i l l include faculty members from Harvard Medical 
School, T j f t s O i i v e r s i t y School of Medicine and the University of Utah College 
of Medicine. For further information, contact the BUSM Department of 
Continuing Medical Education at x5602 (247-5602). 
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BRIEFLY NOCED I ^ u l H. Black, M.D., direct o r of the HumE*irey 
Cancer Research Center, and Donald M. Small, 
M.D., direc t o r of the School's Biophysics I n s t i t u t e , were c i t e d i n the Oct. 12 
issue of Chrrent Contents, published by the I n s t i t u t e f or S c i e n t i f i c 
Information. Ihe publication l i s t s physicians who have been quoted i n 
a r t i c l e s at least 1,000 times i n one year....Leonard S. Gottlieb, M.D., 
chairman of the Department of Pathology and direc t o r of the Mallory I n s t i t u t e 
of Pathology, recently was appointed American editor of the Biopsy Pathology 
S e r i e l , published by Chapman and I f e l l i n Great B r i t a i n . . . .Jose Lopez, M.D., an 
assistant professor of medicine, was a featured speaker at the International 
Symposium on Ovarian Cancer, recently held i n Palma de Mallorca, Spain.... 
Albert Gaw, M.D., an assistant professor of psychiatry and a s t a f f 
p s ychiatrist a t the Edith Nourse Rogers Memorial \feterans Administration 
Medical Center, recently was named president-elect of the caucus of the 
Asian-American Psychiatrists of the American Psychiatric Association for 
1982-83....Donald R. C i l l e r , d i r e c t o r of marketing and public a f f a i r s at BUMC, 
recently was awarded the Evans HDughton Memorial Award by the New England 
Hospital Public Relations Association i n recognition of his contributions t o 
the f i e l d of h o ^ i t a l public relations. 
NfWS & NOTES i s a regular monthly publication of the Office of Informational 
Services. I f you have news of inter e s t t o the School of Medicine community, 
c a l l editor Susan Rabin, x5606 (247-5606), or write t o her at the Office of 
Informational Services, P-600 (720 Harrison Ave., Boston, MA 02118). Marge 
EWyer i s managing editor. 
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